Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Han

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy AdultsAndreas H Groll, Amit Desai, David Han, et al.
Research Square|June 22, 2026
First‑Day Glycemic Exposure and 28‑Day Mortality in the ICU: A Multicohort StudyJoab O Odera, Betsabe G Blas Achic, Julie Cha, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's DiseaseGvido Cebers, Robert C Alexander, Samantha Budd Haeberlein, et al.
Postgraduate Medicine|December 20, 2014
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addictsKenneth Blum, Yijun Liu, Wei Wang, et al.
British Journal of Clinical Pharmacology|April 25, 2022
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjectsShringi Sharma, Xavier Pepin, Jean Cheung, et al.
Cancers|September 14, 2024
The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast CancerDavid Han, Jonathan M Spehar, Dillon S Richardson, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
The British Journal of Oral & Maxillofacial Surgery|April 22, 2022
Reproducibility of a three-dimensional skeletal-based craniofacial orientation method for virtual surgical planningThiago Iafelice Dos Santos, Rafaela Costa Freire, André Luis Fernandes da Silva, et al.
Journal of Behavioral Addictions|July 14, 2015
Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT)Thomas Mclaughlin, Marlene Oscar-Berman, Thomas Simpatico, et al.
Nature Neuroscience|June 16, 2009
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesinGerardo A Morfini, Yi-Mei You, Sarah L Pollema, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy AdultsAndreas H Groll, Amit Desai, David Han, et al.
Research Square|June 22, 2026
First‑Day Glycemic Exposure and 28‑Day Mortality in the ICU: A Multicohort StudyJoab O Odera, Betsabe G Blas Achic, Julie Cha, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's DiseaseGvido Cebers, Robert C Alexander, Samantha Budd Haeberlein, et al.
Postgraduate Medicine|December 20, 2014
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addictsKenneth Blum, Yijun Liu, Wei Wang, et al.
British Journal of Clinical Pharmacology|April 25, 2022
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjectsShringi Sharma, Xavier Pepin, Jean Cheung, et al.
Cancers|September 14, 2024
The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast CancerDavid Han, Jonathan M Spehar, Dillon S Richardson, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
The British Journal of Oral & Maxillofacial Surgery|April 22, 2022
Reproducibility of a three-dimensional skeletal-based craniofacial orientation method for virtual surgical planningThiago Iafelice Dos Santos, Rafaela Costa Freire, André Luis Fernandes da Silva, et al.
Journal of Behavioral Addictions|July 14, 2015
Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT)Thomas Mclaughlin, Marlene Oscar-Berman, Thomas Simpatico, et al.
Nature Neuroscience|June 16, 2009
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesinGerardo A Morfini, Yi-Mei You, Sarah L Pollema, et al.
Pageof 11